Case study (MyBioGate Accelerator)

Project T336

Case Background

Project T336 is a photoacoustic tomography technology from an American company, with leading technology for breast cancer screening. Its prototype is in the clinical trial phase in the U.S., and is finding its product-market fit through hospitals in China.

Given the enormous potential of the China market, the company seeks professional cross-border service providers to help it accelerate growth in China.

Goals and Achievements

Goals:

  • Accelerate pre-market circle, find highly-efficient cooperation.
  • Quickly raise investment and start-up capital. Raise 50 million RMB ($7.14 million USD); complete the technology transfer and registration, and enter the market within three years.
  • Establish operational and marketing teams, find offices and factories, connect clinical resources, establish sales channels, and so forth.

Our achievements:

  • Obtained 45 million-yuan ($6.43 million USD) investment from the MyBioGate Fund, Jiangsu Industrial Technology Research Institute (JITRI), and Taicang Biomedical Industry Fund.
  • The project expected to land in Jiangsu by August 2020, with a 10,000-square-foot.  office and factory space.
  • Clinical research supported by Grade A hospitals in China.
  • Established a professional marketing team for product registration, certification, as well as sales channel establishment.
Our services

Set up a project acceleration team

Evaluate and disseminate project core value

China market development strategy & plan consultation, and business plan polishing

Financing and cooperation resources partnering